Safe Medical Evaluation

About:

Safe Medical Evaluation is a preclinical CRO service provider dedicated to the toxicological testing and safety evaluation of drugs.

Website: https://www.safeglp.com

Top Investors: CICC, Legend Capital, QF Capital, SDIC Venture Capital, Med-Fine Capital

Description:

Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.

Total Funding Amount:

500M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2016-01-01

Contact Email:

info(AT)safeglp.com

Founders:

Liu Yang

Number of Employees:

101-250

Last Funding Date:

2022-12-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai